Related Experiment Video
Updated: Oct 19, 2025

06:32
Author Spotlight: Unlocking Insights into the Immune Cell Landscape of Tumors
Published on: August 18, 2023
2.4K
WES Analysis Measures Immune Infiltration and Predicts Therapy Response
Cancer Discovery
|September 18, 2021
Summary
A new, affordable method analyzes whole-exome sequencing data to measure immune cell infiltration. This approach enhances cancer research by quantifying immune responses cost-effectively.
Area of Science:
- Immunology
- Genomics
- Bioinformatics
Background:
- Accurate quantification of immune infiltration is crucial for understanding tumor microenvironments and predicting treatment response.
- Current methods for assessing immune infiltration can be costly and time-consuming.
- Whole-exome sequencing (WES) data offers a rich source of information but requires specialized bioinformatic tools for immune cell analysis.
Purpose of the Study:
- To develop and validate a novel, cost-effective method for quantifying immune infiltration directly from whole-exome sequencing data.
- To provide researchers with an accessible tool for immune profiling in cancer studies.
Main Methods:
- Development of a computational pipeline that analyzes single-nucleotide variants (SNVs) and copy number alterations (CNAs) from WES data.
- Utilizing machine learning algorithms trained on reference datasets to predict the abundance of various immune cell types.
- Validation of the method using orthogonal techniques such as immunohistochemistry (IHC) and flow cytometry.
Main Results:
- The novel method accurately quantifies the infiltration levels of major immune cell populations (e.g., T cells, B cells, macrophages).
- Results obtained from the WES-based method show high concordance with gold-standard techniques.
- The computational approach demonstrates significant cost savings compared to traditional methods.
Conclusions:
- This cost-effective WES-based method provides a reliable and scalable solution for quantifying immune infiltration.
- The developed tool can facilitate large-scale immune profiling in cancer genomics studies.
- This approach has the potential to improve biomarker discovery and personalize cancer treatment strategies.

